KOPRAN vs NGLFINE: Stock Comparison

Kopran Limited vs NGL Fine-Chem Limited

Live data: 29 May 2026, 4:01 PM IST • Source: NSE and company filings

NGL Fine-Chem Limited is the larger company by market capitalisation. Kopran Limited shows a lower P/E, a higher dividend yield and lower leverage, while NGL Fine-Chem Limited shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Kopran Limited and NGL Fine-Chem Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, KOPRAN is more favourable on 4 of 13 scored metrics and NGLFINE on 9These counts are context-free and are not an overall rating.

Key Differences

Market Cap
NGLFINE is the larger company
₹2,008 Cr vs ₹942 Cr
P/E Ratio
KOPRAN has a lower P/E
38.28x vs 41.23x
P/B Ratio
KOPRAN has a lower P/B
1.86x vs 6.03x
EPS
NGLFINE has higher earnings per share
₹78.04 vs ₹3.41
Dividend Yield
KOPRAN has a higher dividend yield
1.59% vs 0.05%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs -3.66%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs -71.88%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
57.1% vs -3.03%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKOPRANNGLFINE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricKOPRANNGLFINE
Live Price₹206.27₹3,260
Day Change6.56%0.7%
Volume38.55 L5,595
52-Week High₹219₹3,329
52-Week Low₹107₹1,175.5
Distance from 52W High-5.81%-2.07%

Valuation

MetricKOPRANNGLFINE
Market Cap₹942 Cr₹2,008 Cr
P/E Ratio38.28x41.23x
P/B Ratio1.86x6.03x
EPS₹3.41₹78.04
Book Value₹107.35₹532.95
Dividend Yield1.59%0.05%

Growth

MetricKOPRANNGLFINE
Revenue Growth (TTM YoY)-3.66%57.2%
EPS Growth (TTM YoY)-71.88%1,539.8%
Qtr Sales Growth-3.03%57.1%
Qtr Profit Growth-32.9%2,398%

Profitability & Leverage

MetricKOPRANNGLFINE
ROE4.85%15.7%
ROCE9.75%17%
Net Margin3.78%9.59%
Operating Margin6.58%14.5%
Debt to Equity0.29x0.33x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKOPRANNGLFINE
Promoter Holding44.42%72.74%
FII Holding0.51% 0.06 pp0.03% 0.03 pp
DII Holding0%0%
Public Holding55.06% 0.06 pp27.24% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Kopran Limited and NGL Fine-Chem Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.